Group 1: Financial Performance - In 2024, the company achieved a revenue of 161 million yuan, representing a year-on-year growth of 4.21% [2] - The net cash flow from operating activities in 2024 was 65.73 million yuan, an increase of 34.06% compared to the previous year [3] Group 2: Shareholder and Dividend Information - The company plans to complete the dividend distribution for the 2024 fiscal year within two months after the annual shareholders' meeting [2] - Concerns were raised regarding the major shareholder's continuous reduction of holdings, which may impact investor confidence [3] Group 3: Research and Development - As of December 31, 2024, the company held 81 authorized patents, including 30 invention patents, 49 utility model patents, and 2 design patents, along with 25 software copyrights [2] - The company actively participates in the formulation of industry standards and technical conditions, enhancing its market position in the rail safety monitoring sector [2] Group 4: Strategic Planning - The company aims to expand its business across various markets, including national railways and urban rail transit, to achieve a balanced revenue distribution [2] - Future strategic planning will focus on digitalization, information technology, and smart solutions in the rail transportation industry, aligning with national development strategies such as the "Belt and Road" initiative [3]

江西华邦律师事务所 关于江西日月明测控科技股份有限公司 2024年年度股东大会的法律意见书 1、本次股东大会由公司董事会召集。召开本次股东大会的通知已于2025年4 月25日在巨潮资讯网等中国证券监督管理委员会指定信息披露网站上予以公告。 所有议案已在本次股东大会通知公告中列明，相关议案内容已依法披露。 2、本次股东大会采用现场投票与网络投票相结合的方式进行。现场会议于 2025 年 5 月 21 日下午 14:30 在公司八楼会议室召开。网络投票时间为 2025 年 5 月 21 日，其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 5 月 21 日的交易时间，即上午 9:15～9:25，9:30～11:30 和下午 13:00～15:00； 通过深圳证券交易所互联网投票系统进行网络投票的具体时间为 2025 年 5 月 21 日上午 9:15 至下午 15:00 的任意时间。 经核查，本所律师认为，本次股东大会的召集、召开程序符合法律、法规、 规范性文件及《公司章程》的规定。 二、召集人资格 本次股东大会会议召集人是公司董事会。 致：江西日月明测控科技股份有限公司 根据《中华人民共和 ...

证券代码：300906 证券简称：日月明 公告编号：2025-016 江西日月明测控科技股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会不存在否决议案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开时间： 1、现场会议召开时间：2025 年 5 月 21 日（星期三）下午 14:30 2、网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 5 月 21 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证券交易所互联 网投票系统（http://wltp.cninfo.com.cn）投票的具体时间为：2025 年 5 月 21 日 9:15- 15:00。 （二）会议召开地点：江西省南昌市高新技术产业开发区高新四路 999 号，江西日月 明测控科技股份有限公司八楼会议室。 （三）会议召开方式：现场投票与网络投票相结合的方式召开。 （四）会议召集人：公司第四届董事会 ...

公司出席本次活动的人员有：公司董事长、总经理陶捷先生；独立董事刘钰先生；财务 负责人张丽女士；副总经理、董事会秘书尹玮先生。 为充分尊重投资者、提升交流的针对性，现就公司 2024 年度业绩说明会提前向投资者 公开征集问题，广泛听取投资者的意见和建议。投资者可于 2025 年 5 月 20 日（星期二） 16:00 前访问网址 https://ir.p5w.net/zj，或者扫描下方二维码，进入问题征集专题页面 进行提问。公司将在 2024 年度业绩说明会上，就公司 2024 年度业绩、公司治理、发展战 略、经营状况、融资计划、股权激励和可持续发展等投资者关心的问题，与投资者进行沟通 与交流。欢迎广大投资者积极参与。 证券代码：300906 证券简称：日月明 公告编号：2025-015 江西日月明测控科技股份有限公司 关于参加江西辖区上市公司 2025 年投资者网上 集体接待日活动暨召开 2024 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，江西日月明测控科技股份有限公司（以下简称"公 司"）将参加由江 ...

Group 1: 华峰化学 - Company decided to terminate the acquisition of 100% equity in Zhejiang Huafeng Synthetic Resin Co., Ltd. and Zhejiang Huafeng Thermoplastic Polyurethane Co., Ltd. due to insufficient shareholder approval [1] - The decision was made based on prudence, as the proposal did not receive more than two-thirds of the valid voting rights at the shareholders' meeting [1] - Company will continue to promote related equity injection work and strictly fulfill asset injection commitments [1] Group 2: 中荣股份 - Actual controller and chairman Huang Huanran has been placed under residential surveillance by the police [2] - Other board members and senior management are performing their duties normally, and the board of directors is operating as usual [2] - Company specializes in the research, design, production, and sales of paper printing and packaging products [2] Group 3: 密尔克卫 - Three shareholders plan to reduce their holdings by a total of up to 2% of the company's shares through block trading [3] - The reduction includes 143.63 million shares, 97.65 million shares, and 75.03 million shares, representing 0.91%, 0.62%, and 0.47% of the total share capital respectively [3] - The reduction period is from June 6, 2025, to September 5, 2025, due to personal funding needs [3] Group 4: 舒泰神 - Subsidiary Jiangsu Beijietai Biotechnology Co., Ltd. has obtained a drug production license from the Jiangsu Provincial Drug Administration [4] - The license allows for the production of therapeutic biological products, specifically for registered declaration use [4] - The license is valid until May 7, 2030, and is not expected to have a significant impact on the company's current performance [4] Group 5: 捷顺科技 - Company won the bid for the "Chongqing Beautiful Sunshine Home and other public rental housing supporting parking space operation project" [5] - The project includes four public rental housing supporting parking lots with a total of 13,335 parking spaces [5] - The minimum guaranteed revenue for the project is quoted at 40.43 million yuan per year, with a total contract amount expected to exceed 100 million yuan [5] Group 6: 综艺股份 - Company signed an investment cooperation intention agreement to acquire control of Jiangsu Jilai Microelectronics Co., Ltd. through cash capital increase or share transfer [6] - Jilai Micro primarily engages in the research, production, and sales of power semiconductor chips and devices [6] - The transaction is expected to constitute a major asset restructuring [6] Group 7: 东山精密 - Subsidiary DSBJ PTE. LTD. plans to acquire 100% equity of French GMD Group for approximately 100 million euros (about 814 million yuan) [7] - The acquisition aims to advance the company's globalization strategy and enhance its market share in the automotive parts sector [7] - The company specializes in the research, production, and sales of electronic circuit products and precision components [7] Group 8: 诺诚健华 - Company reported a net profit of 17.97 million yuan for the first quarter of 2025, a significant turnaround from a loss of 142 million yuan in the same period last year [8] - The first quarter revenue reached 381 million yuan, representing a year-on-year growth of 129.92% [8] - The company focuses on the research, production, and commercialization of innovative drugs [8] Group 9: 凯美特气 - Shareholders plan to reduce their holdings by up to 3% of the company's shares through centralized bidding and/or block trading [9] - The total number of shares to be reduced is 20.86 million [9] - The reduction is due to personal funding needs [9] Group 10: 海创药业 - Controlling shareholder plans to reduce holdings by up to 2% of the company's shares through centralized bidding and block trading [10] - The total number of shares to be reduced is 1.98 million [10] - The reduction is due to personal funding needs [10] Group 11: 高争民爆 - Controlling shareholder plans to reduce holdings by up to 3% of the company's shares through centralized bidding and block trading [11] - The total number of shares to be reduced is 828,000 [11] - The reduction is due to the company's funding needs [11] Group 12: 金埔园林 - Two shareholders plan to reduce their holdings by a total of up to 1.91% of the company's shares [12] - The reductions include 183.93 million shares and 167.73 million shares [12] - The reasons for the reductions are asset optimization and personal funding needs [12] Group 13: 掌趣科技 - The largest shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding or block trading [13] - The total number of shares to be reduced is 27.2 million [13] - The reduction is due to personal funding needs [13] Group 14: 美凯龙 - Company announced that its director and general manager has been placed under investigation and detention by the local supervisory committee [14] - Other board members and senior management are performing their duties normally, and daily operations are unaffected [14] - The company specializes in managing and operating self-operated and franchised shopping malls [14] Group 15: 新强联 - Major shareholder plans to reduce holdings by up to 1.89% of the company's shares through centralized bidding and block trading [15] - The total number of shares to be reduced is 717,490 [15] - The reduction is due to operational needs [15] Group 16: 日月明 - Shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding [16] - The total number of shares to be reduced is 80,000 [16] - The reduction is due to personal funding needs [16] Group 17: 同有科技 - Major shareholder and vice president plan to reduce their holdings by up to 1.53% of the company's shares [17] - The total number of shares to be reduced is 730,850 [17] - The reduction is due to personal funding needs [17] Group 18: 爱尔眼科 - Subsidiary successfully acquired 60% equity and specific debt of Shenzhen Guangsheng Digital Technology Co., Ltd. for 650 million yuan [18] - The transaction constitutes a related party transaction [18] - The acquired asset will serve as long-term medical premises for the subsidiary [18]

江西日月明测控科技股份有限公司 关于股东减持股份计划预披露公告 股东南昌市国金产业投资有限公司保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示： 持有江西日月明测控科技股份有限公司（以下简称"公司"或"本公司"）股份 2,200,000 股（占公司总股本比例 2.75%）的股东南昌市国金产业投资有限公司（原名：南 昌市国金工业投资有限公司，以下简称"国金产业"）计划自本公告披露之日起 3 个交易 日后的 3 个月内以集中竞价交易方式减持公司股份 800,000 股（占公司总股本比例 1%）。 公司于近日收到股东国金产业出具的《关于股东减持股份计划告知函》，现将有关情 况公告如下： 一、股东的基本情况 1、股东的名称：南昌市国金产业投资有限公司。 2、截至本公告披露日，国金产业持有公司股份的总数量为2,200,000股，占公司总股 本比例2.75%。 证券代码：300906 证券简称：日月明 公告编号：2025-014 "除非公司撤回上市申请，则在公司首次公开发行股票前，本企业将不转让或委托他 人管 ...

Core Viewpoint - The company, 日月明, reported steady growth in its 2024 annual report, highlighting an increase in revenue and net profit, alongside a commitment to innovation and market expansion in the rail transportation sector [1][2]. Financial Performance - The company achieved an operating revenue of 161 million yuan, representing a year-on-year growth of 4.21% [1]. - The net profit attributable to shareholders reached 75.32 million yuan, marking a year-on-year increase of 24.22% [1]. - Earnings per share were reported at 0.94 yuan, with a proposed cash dividend of 5 yuan for every 10 shares, totaling approximately 40 million yuan in cash dividends [1]. Business Strategy and Market Position - The rail transportation industry in China is transitioning to a phase that emphasizes both new line construction and the operation and maintenance of existing lines [1]. - 日月明 is focusing on deepening its business layout and strengthening its core competitive advantages while exploring incremental market opportunities [1]. - The company maintains a leading position in the rail measurement and control field, with a gross margin consistently above 50% [1]. Research and Development - In 2024, the company maintained a high level of R&D investment, with R&D expenses accounting for 10.09% of operating revenue [2]. - 日月明 was granted 10 new patents, including 7 invention patents, and received a first-class award from the China Transportation Association for its project on high-speed rail track dynamic and static irregularity data fusion [2]. - The company has a total of 81 authorized patents, including 30 invention patents, 49 utility model patents, and 2 design patents, along with 25 software copyrights, which are fully applied in its products [2]. Future Outlook - 日月明 plans to leverage the new trends in the rail transportation industry, focusing on digitalization, informatization, intelligence, and networking, while aligning with the national "Belt and Road" initiative [2]. - The company aims to stay at the forefront of various rail transportation technologies to provide advanced equipment and technical solutions to its clients [2].

证券代码：300906 证券简称：日月明 公告编号：2025-013 江西日月明测控科技股份有限公司 关于召开公司 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 江西日月明测控科技股份有限公司（以下简称"公司"）于2025年4月23日召开第四届 董事会第五次会议，审议通过《关于提请召开公司2024年年度股东大会的议案》，现将 2024年年度股东大会有关事项通知如下： 一、召开会议的基本情况 1、股东大会届次：2024 年年度股东大会。 2、股东大会召集人：公司第四届董事会。 3、会议召开的合法、合规性：本次股东大会会议召开符合有关法律、行政法规、部门 规章、规范性文件和《公司章程》的规定。 （1）现场投票:股东本人出席本次会议现场会议或者通过授权委托书委托他人出席现 场会议; （2）网络投票:本次股东大会通过深圳证券交易所交易系统和互联网投票系统 （http://wltp.cninfo.com.cn）向全体股东提供网络形式的投票平台，股权登记日登记在 册的公司股东可以在网络投票时间内通过上述系统行使表决权。 公司股东应选择现场 ...

证券代码：300906 证券简称：日月明 公告编号：2025-006 江西日月明测控科技股份有限公司 第四届监事会第五次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 江西日月明测控科技股份有限公司（以下简称"公司"）第四届监事会第五次会议通 知已于2025年4月13日通过电话、邮件等方式送达全体监事。会议于2025年4月23日16:00以 现场会议的方式召开，现场会议在公司八楼会议室。本次会议由监事会主席杜娇娜女士召 集并主持，应出席监事3人，实际出席监事3人。本次会议的召集、召开符合《中华人民共 和国公司法》等法律、行政法规、部门规章、规范性文件和《公司章程》的有关规定，会 议合法、有效。 二、监事会会议审议情况 经与会监事认真审议，充分讨论，以记名投票方式逐项表决，会议审议通过了以下议 案： 1、审议通过《关于<2024年度监事会工作报告>的议案》。 监事会主席杜娇娜女士作《2024年度监事会工作报告》，具体内容详见公司披露于巨 潮资讯网（http://www.cninfo.com.cn）的《2024年度监事会工作报 ...

证券代码：300906 证券简称：日月明 公告编号：2025-005 江西日月明测控科技股份有限公司 第四届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 江西日月明测控科技股份有限公司（以下简称"公司"）第四届董事会第五次会议通 知已于2025年4月13日通过电话、邮件等方式送达全体董事。会议于2025年4月23日15:00以 现场会议的方式召开，现场会议在公司八楼会议室。本次会议由董事长陶捷先生召集并主 持，应出席董事7人，实际出席董事7人。公司监事、高级管理人员列席了会议。本次会议 的召集、召开符合《中华人民共和国公司法》等法律、行政法规、部门规章、规范性文件 和《公司章程》的有关规定，会议合法、有效。 二、董事会会议审议情况 经与会董事认真审议，充分讨论，以记名投票方式逐项表决，会议审议通过了以下议 案： 1、审议通过《关于<2024年度总经理工作报告>的议案》。 公司总经理陶捷先生作《2024年度总经理工作报告》，报告对2024年度经营情况进行 了总结，对2025年度发展战略和经营计划进行了分析和展望 ...